TMCnet

Anumana Advances AI-Driven Cardiovascular Science with Late-Breaking Heart Failure Study and Multiple Abstracts at AHA 2025

Anumana, a leader in AI-powered cardiovascular diagnostics, today announced new groundbreaking clinical data presented at the American Heart Association (AHA) Scientific Sessions 2025. Among the ...

Industry Demand is Driving AI Adoption From the Ground Up in Latin America. Here’s What to Expect in 2026

Detailed price information for JP Morgan Chase & Company (JPM-N) from The Globe and Mail including charting and trades.

George Medicines presents long-term efficacy and safety data for single pill triple combination therapy for hypertension at American Heart Association’s Scientific Ses…

George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs in cardiometabolic ...

SMX and CARTIF Plan to Make Spain the EU’s “Capital of Verified Circularity”

NEW YORK, NY / ACCESS Newswire / November 5, 2025 / Every generation reaches a point when progress demands proof. For Europe, following Singapore’s unprecedented action to usher in circularity, that ...
Le Lézard

Merck's Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Phase 3 CORALreef Lipids Trial

Merck , known as MSD outside of the United States and Canada, today announced the first presentation of results from the pivotal Phase 3 CORALreef Lipids trial demonstrating that treatment with ...